Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Cannell & Spears LLC

robot
Abstract generation in progress

Cannell & Spears LLC increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 13.7% in the third quarter, bringing their total holdings to $16.913 million. The article also details other institutional investor activity, recent analyst ratings, insider stock sales, and the company’s financial performance, including a recent dividend increase.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin